NATPARA^® is a parathyroid hormone indicated as an adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism. Because of the potential risk of osteosarcoma, NATPARA is recommended only for patients who cannot be well-controlled on calcium supplements and active forms of vitamin D alone. NATPARA was not studied in patients with hypoparathyroidism caused by calcium-sensing receptor mutations. NATPARA was not studied in patients with acute post-surgical hypoparathyroidism.

See full indication

See less indication

See full indication

See less indication

We help prepare your patients to self-administer NATPARA

How we can help your patients get started

All patients prescribed NATPARA are provided injection training by a Registered Nurse through the NATPARA Nurse Educator team. A Patient Support Manager works with the Nurse Educator team to assign each patient a specially trained NATPARA Nurse Educator. The Nurse Educator will contact the patient within 2 business days of receiving his/her NATPARA shipment to schedule up to 4 sessions of complimentary training in the patient's home, including:

Delivering the injection device and demonstrating how to assemble it
Walking through the reconstitution and administration process for the first 3 cartridges (Days 1, 15, and 29 of treatment)
Calling the patient after each training to check in and answer any questions
Providing materials to help patients take an active role in their treatment

When patients are mixing the cartridge alone for the first time, there will be a Nurse Educator on the phone

Questions or concerns?

Please call 1-866-888-0660, Monday through Friday,
8:30 AM to 8:00 PM ET

Learn About Dosing & Administration

Reference: 1. NATPARA [package insert]. Shire Pharmaceuticals, Inc.